Photo: 6okean/Getty Images

San Francisco banned e-cigarettes on Tuesday, citing a "growing health epidemic of youth vaping."

The big picture: San Francisco is now the first major U.S. city to ban e-cigarettes, NBC reports. Juul, which is headquartered in San Francisco, tried to crack down on youth vaping in 2018, but this didn't prevent the FDA from stepping in to start to address the problem.

Details: The city's ban will restrict "the sale, manufacture, and distribution of tobacco products — including electronic cigarettes," according to the new health code ordinance.

  • The ban also "prohibits the sale and distribution of flavored tobacco products and electronic cigarettes that require, but have not received, an FDA order approving their marketing."

Flashback: In an effort to reduce youth vaping, the FDA released its formal proposal to restrict the sale of flavored tobacco products in March.

A Juul Labs spokesperson said in a statement:

"This full prohibition will drive former adult smokers who successfully switched to vapor products back to deadly cigarettes, deny the opportunity to switch for current adult smokers, and create a thriving black market instead of addressing the actual causes of underage access and use. We have already taken the most aggressive actions in the industry to keep our products out of the hands of those underage and are taking steps to do more. 
We will continue to work with local policymakers, small businesses, community leaders and adult smokers who have switched to vapor products to enact stronger regulation and enforcement rather than complete prohibition, because this will primarily drive adult smokers back to cigarettes, which remain untouched by this legislation, even though they kill 40,000 Californians every year."

Go deeper: Tobacco use is soaring among U.S. kids, driven by e-cigarettes

Editor's note: This story was corrected to show the ban largely affects flavored tobacco products and e-cigarettes that require, but have not received, an FDA order approving their marketing (not that the ban would affect all tobacco products).

Go deeper

Dan Primack, author of Pro Rata
1 hour ago - Economy & Business

GoodRx prices IPO at $33 per share, valued at $12.7 billion

Illustration: Sarah Grillo/Axios

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday night raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.

Updated 1 hour ago - Politics & Policy

House Democrats and Trump admin strike deal to avert government shutdown

House Speaker Nancy Pelosi on Capitol Hill. Photo: Tom Williams/CQ-Roll Call via Getty Images

The House on Tuesday passed legislation to fund the government through Dec. 11, by a vote of 359-57.

Why it matters: The bill will avert a government shutdown when funding expires in eight days. Pelosi and House Majority Leader Steny Hoyer (D-Md.) said earlier that they hoped to hold a vote on the legislation on Tuesday evening.

Scoop: Meadows puts agencies on notice about staff shake-up

Internal government email obtained by Axios

White House chief of staff Mark Meadows told administration officials Monday to expect senior aides to be replaced at many government agencies, according to an internal email obtained by Axios.

Behind the scenes: Meadows asked the director of the White House Presidential Personnel Office John McEntee "to look at replacing the White House Liaisons (WHLs) at many of your agencies," according to the email. "John will be working with outgoing liaisons to explore other opportunities."

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!